The U.S. Food and Drug Administration issued an emergency use authorization or EUA for investigational convalescent plasma to treat COVID-19 in hospitalized patients.
The blood from those people who have recovered from the disease is called convalescent plasma. Plasma is the liquid portion of the blood. After viral infection, one's plasma contains antibodies that can be used to fight infection.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com